Receptor/Gene-Mediated Pharmacodynamic Effects of Methylprednisolone on Phosphoenolpyruvate Carboxykinase Regulation in Rat Liver
- 13 January 2004
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Journal of Pharmacology and Experimental Therapeutics
- Vol. 309 (1), 328-339
- https://doi.org/10.1124/jpet.103.061515
Abstract
Phosphoenolpyruvate carboxykinase (PEPCK) is the rate-limiting enzyme for gluconeogenesis. To investigate underlying mechanisms of corticosteroid (CS) action in regulating glucose, temporal patterns of hepatic PEPCK gene expression, enzyme activity, and cAMP content were examined in adrenalectomized rats receiving acute and chronic methylprednisolone (MPL) treatments. After single MPL intravenous doses, PEPCK mRNA showed a fast increase, reaching a maximum at around 0.75 h, which was followed by an immediate decline to below baseline after 4 h, an apparent acute tolerance/rebound phenomenon. However, PEPCK enzyme showed continuous hyperactivity for over 72 h. This may be the result of generation of cAMP, an important inducer of PEPCK activity, which peaked at around 6 h. During 7-day subcutaneous infusion of MPL, PEPCK mRNA showed profiles consistent with single-dose results, whereas PEPCK activity increased to a comparable maximum followed by a slow decline. However, the extent of cAMP induction was markedly higher during infusion, which could be attributed to amplification of cAMP synthesis and/or a stabilizing effect of MPL on cAMP degradation. A pharmacokinetic/pharmacodynamic model was developed based on receptor/gene mechanisms of CS action. It successfully described the dual effects of MPL on regulating PEPCK message and the post-transcriptional control by cAMP. Our results exemplify the importance of the extent and duration of steroid exposure in mediating pharmacological effects. The model provides quantitation of multiple controlling factors regulating PEPCK and presents insights into its function in glucose metabolism.Keywords
This publication has 32 references indexed in Scilit:
- Transit Compartments versus Gamma Distribution Function To Model Signal Transduction Processes in PharmacodynamicsJournal of Pharmaceutical Sciences, 1998
- PEPCK Gene as Model of Inhibitory Effects of Insulin on Gene TranscriptionDiabetes Care, 1990
- Studies on the degradative mechanism of phosphoenolpyruvate carboxykinase from the yeast Saccharomyces cerevisiaeBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1989
- Studies of Glucocorticoid Enhancement of the Capacity of Hepatocytes to Accumulate Cyclic AMPBasic & Clinical Pharmacology & Toxicology, 1989
- Cooperative effect of thyroid and glucocorticoid hormones on the induction of hepatic phosphoenolpyruvate carboxykinase in vivo and in cultured hepatocytesEuropean Journal of Biochemistry, 1986
- Insulin modulation of gene expressionDiabetes/Metabolism Research and Reviews, 1985
- Regulation of citrate synthase and phosphoenolpyruvate carboxykinase by hydrocortisone in the liver of aging ratsArchives of Gerontology and Geriatrics, 1984
- Changes in hormone responsiveness and cyclic AMP metabolism in rat hepatocytes during primary culture and effects of supplementing the medium with insulin and dexamethasoneEuropean Journal of Biochemistry, 1984
- Effect of cordycepin and cycloheximide on the induction of phosphoenolpyruvate carboxykinase by dexamethasone or N6, O2′‐dibutyryl cyclic AMPFEBS Letters, 1975
- Induction of phosphoenolpyruvate carboxykinase by N6,O2′-dibutyryl cyclic amp in rat liverBiochimica et Biophysica Acta (BBA) - General Subjects, 1972